Scholars Central

Review articlePublished 2016

Controversies in the Management of Patent Ductus Arteriosus in Preterm Infants

Authors: Neha Chaudhary, Panayot Filipov, Alok Bhutada, Shantanu Rastogi

Journal of Neonatal Biology

Volume 5 · Issue 4 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Patent Ductus Arteriosus (PDA) is present in 40-60 percent of preterm infants with its incidence inversely proportional to the gestational age. Management of PDA in extreme prematurity and extremely low birth weight infants is controversial specially with newer literature showing no significant benefits in long term outcomes in infants who were treated as compared to those who were not treated. Further the mortality and morbidities in preterm infants may not be entirely related to PDA as previously ascribed. Hence there is controversy as to which preterm infants benefit from treatment, when should they be treated and which treatment modalities should be used. We have reviewed the current literature to bring out the controversies in the answer to these questions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neonatal Biology
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Neha Chaudhary”
  • BylineArticles whose byline prints “Panayot Filipov”
  • BylineArticles whose byline prints “Alok Bhutada”
  • BylineArticles whose byline prints “Shantanu Rastogi”